Agency for Health Economic Assessment and Dissemination
About Us
The Agency for Health Economic Assessment and Dissemination – AHEAD - is a specialized
consulting agency that supports clients in the planning, generation and dissemination of health economic evidence as well as in obtaining market access and reimbursement in Germany.
Health Economic Evidence Assessment
Planning: Determination which health economic assessments are essential for your product from the market launch, the HTA/payer and the KOL/provider perspective.
Generation: Development and application of health economic evaluations and/or models in order to generate the health economic evidence for your product.
Dissemination: Communication of the health economic value messages (based on the health economic assessment results) to decision makers, payers, providers & KOLs.
Market Access and Reimbursement in Germany
Market Access & Reimbursement: Evaluation and implementation of market access strategies and of reimbursement strategies for digital health applications, medical devices and for pharmaceuticals in Germany.
The AHEAD philosophy is to provide high-quality, product-specific and client-need-specific
consulting & research activities that will be delivered on time.
Contact
General Manager
AHEAD GmbH
Waschhausgasse 17
D-79540 Loerrach, Germany
Phone + 49 (0) 7621 583 8125
Faxelle+ 49 (0) 7621 583 8153
Mobile + 49 (0) 1577 194 8125
E-Mail Bjoern.Schwander@ahead-net.de
Please download and save the AHEAD - Capability Presentation and the AHEAD - Capability Presentation including Project Showcases.
Our professional indemnity and general liability are secured by the exali insurance for consulting companies.
News
Great News: Our joint research article named “Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success” has been accepted as open access publication in PharmacoEconomics and is already available here.
We are happy to announce publication of our joint epidemiologic research named “Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study” in the journal “Orphanet Journal of Rare Diseases”. Due to the support of German key centers and KOLs in the field of aTTP it was possible to develop and conduct a study that was accepted by the G-BA / IQWiG for estimation the aTTP patient population in Germany. Great thanks again to all that have participated to this research! The full text of the article is available here
Our joint research named “Cost of ownership assessment for a da Vinci robot based on US real-world data” that was developed in cooperation with CAVA Robotics has just been published in the International Journal of Medical Robotics and Computer Assisted Surgery. The full text of the article is available here.
Our organized session proposal named "Health economic modeling of obesity prevention and therapy: insights on published approaches and discussion of alternative methodologies" held at the iHEA congress in Basel (13-17th July 2019) was a great success.